Article Text
PDF
Statistics from Altmetric.com
Footnotes
-
↵1 John Moore underwent treatment for hairy-cell leukaemia at the Medical Center of the University of California. He claimed that his physician and other defendants used his cells in potentially lucrative medical research without his permission and that he had a proprietary interest in each of the products that any of the defendants might ever create from his cells or the patented cell line. The court held that the complaint stated a cause of action for breach of the physician’s disclosure obligations, but not for “conversion” which is a legal term for a “wrongful act of dealing with goods in a manner inconsistent with the rights of the person entitled thereto, with the intention of denying his title or asserting a right inconsistent with it”.9
Read the full text or download the PDF:
Other content recommended for you
- Bodily rights and property rights
- International requirements for consent in biobank research: qualitative review of research guidelines
- Turning residual human biological materials into research collections: playing with consent
- New European guidelines for the use of stored human biological materials in biomedical research
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- The human body as property? Possession, control and commodification
- Ethics of dead participants: policy recommendations for biobank research
- Broadening consent—and diluting ethics?
- Is the commercialisation of human tissue and body material forbidden in the countries of the European Union?
- Organoids as hybrids: ethical implications for the exchange of human tissues